Caroverin and Inner Ear Diseases
NCT01174979
·
clinicaltrials.gov ↗
PHASE3
Phase
SUSPENDED
Status
170
Enrollment
INDUSTRY
Sponsor class
Stopped
due to less patient the study was suspended
Conditions
Tinnitus
Interventions
DRUG:
Caroverin
Sponsor
Phafag AG